おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Zhishan Weixin Biotechnology
company
About
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases.
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Product Research
- Founded date
- Jan 1, 2018
- Operating Status
- Active
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Zhishan Weixin Biotechnology has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Feb 9, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 9, 2021 | Series A | — | 3 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Zhishan Weixin Biotechnology is funded by 3 investors.
Zhengxingu Capital
and Leimei Ruisi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
Leimei Ruisi
|
— | Series A |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
